The effectiveness of resuscitation in patients with acute myocardial infarction according to the population register

Aim To study clinical and anamnestic features and tactics of managing patients with acute myocardial infarction (MI) in groups with different effectiveness of resuscitation procedures.
Materials and methods Patients were selected using the “Acute Myocardial Infarction Registry” epidemiological program. 219 cases of acute MI recorded from 2007 through 2017, which required emergency life support, were studied. Two groups were formed based on success of the resuscitation: group 1 consisted of patients with acute MI who survived due to the cardiovascular life support (n=61); group 2 included fatal cases after resuscitation failure (n=158). Quantitative variables were described as median and interquartile range, Ме (Q1; Q3); comparison was performed in two independent samples using the Mann-Whitney test. Qualitative variables were presented as absolute and relative values (n (%)). Statistical significance of differences in nominal properties was determined with contingency tables (Pearson χ2; two-tailed Fisher’s exact test). Critical level of two-tailed significance was set equal to 0.05.
Results The groups consisted of severe cases at baseline. The groups were sex- and age-matched. Mean age of patients in groups 1 and 2 was 63.5±13.1 and 60.9±14.8 years, respectively (р=0.2); in both groups, females were considerably older than males. Analysis of preceding drug therapy showed that comparable proportions of patients received antihypertensive and/or anti-ischemic treatment; however, the qualitative composition of the therapies was significantly different in these group. Thus, survived patients more frequently than deceased patients received drugs from vitally important groups, including β-blockers (93 % and 13 %, р<0.001), antiplatelets (97 % and 13 %, р<0.001), statins (84 % and 5 %, р<0.001), and angiotensin-converting enzyme (ACE) inhibitors (90 % and 8 %, р<0.001). In additions. success of resuscitation procedures was interrelated with the clinical picture. Thus, in atypical MI, the rate of fatal outcomes was higher (89 % and 56.5 %, р<0.001) despite the life support.
Conclusion The patients who survived due to resuscitation procedures more frequently had a history of adequate drug therapy for ischemic heart disease and arterial hypertension with β-blockers, ACE inhibitors, antiplatelets, and statins. In this group, MI mostly had a clinical picture of a prolonged anginal attack. The long-term prediction for survivors after successful resuscitation presently remains important and requires further study.

1. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal. 2018;39(2):119–77. DOI: 10.1093/eurheartj/ehx393

2. Garganeeva A.A., Borel K.N., Okrugin S.A., Kuzheleva E.A. Predictors of lethality in young patients with acute myocardial infarction. Clinical Medicine. 2017;95(8):713–8.

3. Monsieurs KG, Nolan JP, Bossaert LL, Greif R, Maconochie IK, Nikolaou NI et al. European Resuscitation Council Guidelines for Resuscitation 2015. Resuscitation. 2015;95:1–80. DOI: 10.1016/j.resuscitation.2015.07.038

4. Tarakanova L.I., Mihajljuk S.G., Haller I.V., Miroshnichenko A.G. Evaluation of the significance of factors influencing the results of resuscitation activities at the pre-hospital stage. Emergency Medical Care. 2006;7(4):3–6.

5. Okrugin S.A., Kuzheleva E.A., Garganeeva A.A. World Health Organization project “acute myocardial infarction registry”: epidemiological monitoring of acute coronary catastrophes. Complex Issues of Cardiovascular Diseases. 2018;7(1):76–83. DOI: 10.17802/2306-1278-2018-7-1-76-83

6. Zukhovitskaya E.V. Etiology, pathogenesis and prevention methods of sudden cardiac death in patients with coronary artery disease. Journal of the Grodno State Medical University. 2007;1(17):44–8.

7. Radchenko A.D. Why are we afraid to administer beta-blockers in arterial hypertension? Ukrainian Cardiology Journal. 2013;4:66–90.

8. Korobko I.Yu., Pavlova O.S., Netchesova T.A. Beta-blockers in arterial hypertension and coronary heart disease treatment. Healthcare (Minsk). 2016;9:66–70.

9. Makolkin V.I. Beta-adrenergic blockers remain the drugs of choice in the treatment of arterial hypertension. Russian Heart Journal. 2009;8(3):138–9.

10. Gruzdeva A.A., Hohlov A.L., Kostylev A.I., Beloborodova E.V. The effect of ACE inhibitor therapy on myocardial infarction on endothelial dysfunction. Journal Biomed. 2010;3:60–2.

11. Nissen S., Tuzcu E., Libby P., Thompson P., Ghali M., Garza D. et al. Effects of antihypertensive drugs on cardiovascular events in patients with coronary heart disease and normal blood pressure. Randomized controlled CAMELOT study. Arterial Hypertension. 2005;11(2):125–31.